Here's why some high-risk patients aren't getting drugs to combat COVID
INSUBCONTINENT EXCLUSIVE:
Medicines such as Paxlovid were hailed as an important way to help reduce the risk of severe illness or death from COVID-19
A new study explores why many vulnerable patients didn't get them.
